Hepatocyte GP73 expression in Wilson disease

Journal of Hepatology

Volumn 51, Issue 3, 2009, Pages 557-564

  Wright, Lorinda M ^a,b   Huster, Dominik ^c   Lutsenko, Svetlana ^d   Wrba, Fritz ^e   Ferenci, Peter ^e   Fimmel, Claus J ^a,b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atp7b; Copper; Golgi; Knockout mouse; Liver

Indexed keywords

MESSENGER RNA; PROTEIN; PROTEIN GP73; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; HEPATITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER FIBROSIS; MALE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WILSON DISEASE;

ADENOSINE TRIPHOSPHATASES; ADOLESCENT; ADULT; ANIMALS; BIOLOGICAL MARKERS; BIOPSY; CATION TRANSPORT PROTEINS; CHILD; COPPER; DISEASE MODELS, ANIMAL; FEMALE; HEPATOCYTES; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; PHOSPHOPROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 68049123103     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.05.029     Document Type: Article

References (30)

1. Iftikhar R., Kladney R.D., Havlioglu N., Schmitt-Graff A., Gusmirovic I., Solomon H., et al. Disease- and cell-specific expression of GP73 in human liver disease. Am J Gastroenterol 99 (2004) 1087
2. Kladney R.D., Bulla G.A., Guo L., Mason A.L., Tollefson A.E., Simon D.J., et al. GP73, a novel Golgi-localized protein upregulated by viral infection. Gene 249 (2000) 53
3. Kladney R.D., Cui X., Bulla G.A., Brunt E.M., and Fimmel C.J. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology 35 (2002) 1431
4. Bachert C., Fimmel C., and Linstedt A.D. Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma. Traffic 8 (2007) 1415
5. Marrero J.A., Romano P.R., Nikolaeva O., Steel L., Mehta A., Fimmel C.J., et al. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol 43 (2005) 1007
6. Ferenci P. Wilson's disease. Clin Gastroenterol Hepatol 3 (2005) 726
7. Ferenci P., Caca K., Loudianos G., Mieli-Vergani G., Tanner S., Sternlieb I., et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 23 (2003) 139
8. Ferenci P., Steindl-Munda P., Vogel W., Jessner W., Gschwantler M., Stauber R., et al. Diagnostic value of quantitative hepatic copper determination in patients with Wilson's disease. Clin Gastroenterol Hepatol 3 (2005) 811
9. Kingston H.M., and Jassie L.B. Microwave energy for acid decomposition at elevated temperatures and pressures using biological and botanical samples. Anal Chem 58 (1986) 2534
10. Batts K.P., and Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19 (1995) 1409
11. Buiakova O.I., Xu J., Lutsenko S., Zeitlin S., Das K., Das S., et al. Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation. Hum Mol Genet 8 (1999) 1665
12. Huster D., Finegold M.J., Morgan C.T., Burkhead J.L., Nixon R., Vanderwerf S.M., et al. Consequences of copper accumulation in the livers of the Atp7b-/- (Wilson disease gene) knockout mice. Am J Pathol 168 (2006) 423
13. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402
14. Pfaffl M.W., Horgan G.W., and Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30 (2002) e36
15. de Bie P., Muller P., Wijmenga C., and Klomp L.W. Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. J Med Genet 44 (2007) 673
16. Panagiotakaki E., Tzetis M., Manolaki N., Loudianos G., Papatheodorou A., Manesis E., et al. Genotype-phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B). Am J Med Genet A 131 (2004) 168
17. Steindl P., Ferenci P., Dienes H.P., Grimm G., Pabinger I., Madl C., et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology 113 (1997) 212
18. Fox P.L., Mukhopadhyay C., and Ehrenwald E. Structure, oxidant activity, and cardiovascular mechanisms of human ceruloplasmin. Life Sci 56 (1995) 1749
19. Ritland S., Skrede S., and Johansen O. A long-term follow-up study of the hepatic copper and serum ceruloplasmin concentrations in patients with chronic liver disease. Scand J Gastroenterol 17 (1982) 545
20. Wright L.M., Yong S., Picken M.M., Rockey D., and Fimmel C.J. Decreased survival and hepato-renal pathology in mice with C-terminally truncated GP73 (GOLPH2). Int J Clin Exp Pathol 2 (2009) 34
21. Ferenci P. Pathophysiology and clinical features of Wilson disease. Metab Brain Dis 19 (2004) 229
22. Nagasaka H., Inoue I., Inui A., Komatsu H., Sogo T., Murayama K., et al. Relationship between oxidative stress and antioxidant systems in the liver of patients with Wilson disease: hepatic manifestation in Wilson disease as a consequence of augmented oxidative stress. Pediatr Res 60 (2006) 472
23. Samuele A., Mangiagalli A., Armentero M.T., Fancellu R., Bazzini E., Vairetti M., et al. Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson's disease. Biochim Biophys Acta 1741 (2005) 325
24. Lu Y., Yi Y., Liu P., Wen W., James M., Wang D., et al. Common human cancer genes discovered by integrated gene-expression analysis. PLoS ONE 2 (2007) e1149
25. Varambally S., Laxman B., Mehra R., Cao Q., Dhanasekaran S.M., Tomlins S.A., et al. Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer. Neoplasia 10 (2008) 1285
26. Iwadate H., Ohira H., Suzuki T., Abe K., Yokokawa J., Takiguchi J., et al. Hepatocellular carcinoma associated with Wilson's disease. Intern Med 43 (2004) 1042
27. Xu R., Bu-Ghanim M., Fiel M.I., Schiano T., Cohen E., and Thung S.N. Hepatocellular carcinoma associated with an atypical presentation of Wilson's disease. Semin Liver Dis 27 (2007) 122
28. Huster D., Purnat T.D., Burkhead J.L., Ralle M., Fiehn O., Stuckert F., et al. High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease. J Biol Chem 282 (2007) 8343
29. Puri S., Bachert C., Fimmel C.J., and Linstedt A.D. Cycling of early Golgi proteins via the cell surface and endosomes upon lumenal pH disruption. Traffic 3 (2002) 641
30. Lim C.M., Cater M.A., Mercer J.F., and La Fontaine S. Copper-dependent interaction of dynactin subunit p62 with the N-terminus of ATP7B but not ATP7A. J Biol Chem 281 (2006) 14006